{
    "title": "AstraZeneca shares rise on early U.S. approval for leukaemia drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7715167/AstraZeneca-shares-rise-early-U-S-approval-leukaemia-drug.html",
    "date": "2019-11-22",
    "keywords": [
        "drug",
        "calquence",
        "fda",
        "lymphoma",
        "bryan",
        "garnier",
        "year",
        "frankfurt",
        "friday",
        "drugmaker",
        "approval",
        "challenge",
        "thursday",
        "food",
        "administration",
        "leukemia",
        "leukaemia",
        "speedy",
        "review",
        "programme",
        "collaboration",
        "canada",
        "australia",
        "disease",
        "abbvie",
        "johnson",
        "amp",
        "treatment",
        "light",
        "brokerage",
        "record",
        "speed",
        "momentum",
        "cancer",
        "business",
        "tagrisso",
        "shift",
        "market",
        "share",
        "leader",
        "side",
        "gmt",
        "gain",
        "stoxx",
        "health",
        "care",
        "index",
        "revenue",
        "growth",
        "analyst",
        "jampj",
        "imbruvica",
        "group",
        "mantle",
        "cell",
        "mcl",
        "therapy",
        "reporting",
        "burger",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}